LEADGENE
Language
EN
TW
Leadgene Leadgene
  • Products
    Products
    Product Types
    • Overview
    • GMP-Grade Products
    • IVD Products
    • Protein Engineering
    • Molecular Biology
    • Enzymes
    • Primary Antibodies
    • Secondary Antibodies
    • Recombinant Proteins
    • Cell Biology Reagent
    • ELISA Kits
    • Rapid Test Products
    • Buffers
    Resources
    • Chronic Kidney Disease
    • Nipah Virus
    • COVID-19
    • Cell Biology
    • Cardiovascular
    • Cancer
    • Dengue Virus
    • Epigenetics and Nuclear Signaling
    • Enterovirus
    • Human Respiratory Ryncytial Virus
    • Hepatitis B Virus
    • Influenza Virus
    • Isotype and Loading Controls
    • Immunology
    • Neuroscience
    • Organoid
    • Signal Transduction
    • Tags and Cell Markers
    • Zika Virus
    Close
  • Services
    Services

    Services

    We Innovate.
    We Explore.
    We Contribute.

    • Overview
    • Synthesis Service
    • Protein Service
    • Antibody Service
    • Development & Manufacture
    • Animal Model Analysis
    Close
  • Chronic Kidney Disease
    Chronic Kidney Disease

    Chronic Kidney Disease

    Hello, Kidney Health!

    • Health Education
    • Products
    Close
  • Quality
    Quality

    Quality

    Excellence in Our Profession
    Through Attention to Detail.

    • Quality Control
    Close
  • Support
    Support

    Support

    Bring You a New Vision of the World.

    • Scientific Knowledge
    • Literature
    • Protocol
    • FAQ
    Close
  • Company
    Company

    Company

    Details make our Profession.

    • About us
    • Contact Us
    • Distributors
    • News
    Close
  • Product Search
    COA Search
LEADGENE / Company

News

Latest News

2024.02.17

World Premiere: Leadgene Biomedical's Indoxyl Sulfate (IS) ELISA Kit Secures TFDA Approval

2024.01.22

Leadgene Biomedical Embraces Openness and Strategic Partnerships for Global Market Expansion

2023.12.25

Nanobody Development: Pioneering Tiny Titans for Next-Generation Biotechnology

2023.11.02

Leadgene Biomedical Achieves Recognition as a Domestic CRO Service Company!

2023.10.03

Leadgene Biomedical CEO Honored with 2023 Best Bio CEO Second Prize & Best Potential Prize

2023.09.06

Leadgene Biomedical Wins 2023 Taipei Biotech Awards - Innovation Special Mention Awards

2023.08.11

Leadgene Biomedical Achieves Milestone Recognition, Paving the Way for Advanced Kidney Disease Diagnostics in Taiwan

2023.07.24

Leadgene Biomedical, Inc. Aims for IPO within Three Years Driven by Reagent Raw Materials and Uremic Toxin Detection Kit

2023.04.27

Indoxyl Sulfate Antibody Secures Second U.S. Patent

2023.03.13

Leadgene Indoxyl Sulfate ELISA Kit Helps Medical Institutions Seize the Golden Treatment Period for Kidney Disease

2022.11.10

31st National Award of Outstanding SMEs Awarded!

2023.03.14

New Distributor Announcement - AS ONE Corporation

  • 1
  • 2
  • 3
  • 4
  • Products
    • Overview
    • GMP-Grade Products
    • IVD Products
    • Protein Engineering
    • Molecular Biology
    • Enzymes
    • Primary Antibodies
    • Secondary Antibodies
    • Recombinant Proteins
    • Cell Biology Reagent
    • ELISA Kits
    • Rapid Test Products
    • Buffers
  • Services
    • Overview
    • Synthesis Service
    • Protein Service
    • Antibody Service
    • Development & Manufacture
    • Animal Model Analysis
  • Chronic Kidney Disease
    • Health Education
    • Products
  • Quality
    • Quality Control
  • Support
    • Scientific Knowledge
    • Literature
    • Protocol
    • FAQ
  • Company
    • About us
    • Contact Us
    • Distributors
    • News
  • Terms and Conditions
  • Privacy Policy
© 2025 LEADGENE BIOMEDICAL, INC. All rights reserved.
This site uses cookies as described in our Privacy Policy in order to improve your user experience and deliver customized advertising to you. Click “I Agree” to consent and continue.